Trial intelligence / Profile preview

Saccharomyces Boulardii in Liver Transplant Waiting List

NCT01762748Phase 2Completed

Sponsor
Universidade Federal de Minas Gerais
Start
Jan 2011
Primary completion
Dec 2012
Modality
Microbiome Therapeutics
Countries
1
01

Overview

A Phase 2 trial of saccharomyces boulardii in Liver cirrhosis (LC), sponsored by Universidade Federal de Minas Gerais. Started Jan 2011; status: completed.

02

Drugs

saccharomyces boulardii
03

Conditions

Liver cirrhosis (LC)

Beyond the preview

Go deeper on NCT01762748.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01762748.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call